Outlook Therapeutics raises ~$5M in registered direct offering and private placement at $0.31/unit

Outlook Therapeutics, Inc.

Offering of 16,129,033 shares of common stock and accompanying Common Warrants at $0.31 per unit.
Gross proceeds approximately $5.0 million; net proceeds for working capital and general corporate purposes.
Common Warrants exercisable at $0.31 per share, subject to stockholder approval and increase in authorized shares.
Concurrent warrant amendment reduces exercise price of 2,142,854 existing warrants from $2.26 to $0.31.
H.C. Wainwright acted as placement agent with 7.0% cash fee and warrants for 1,129,032 shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.